Researchers examined the expression levels and survival dates of Inositol 1,4,5-Triphosphate Receptor Family (ITPRs) in patients with pancreatic cancer. As a result, they identified that ITPR1 and ITPR3 expression levels were significantly elevated in cancerous specimens.
[Aging]